Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

TransEnterix Inc. (TRXC) (TRXC)

0.41   0.03 (7.89%) 04-09 16:00
Open: 0.4 Pre. Close: 0.38
High: 0.42 Low: 0.38
Volume: 1,883,281 Market Cap: 19M
TransEnterix Inc is a medical device company engaged in the development and commercialization of a robotic assisted surgical system called the SurgiBot System.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 0.38 - 0.381 0.381 - 0.383
Low: 0.346 - 0.348 0.348 - 0.349
Close: 0.377 - 0.38 0.38 - 0.382

Technical analysis

as of: 2020-04-09 10:06:14 AM
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Target: Six months: 0.57     One year: 0.67
Support: Support1: 0.36    Support2: 0.28
Resistance: Resistance1: 0.49    Resistance2: 0.57
Pivot: 0.36
Moving Average: MA(5): 0.36     MA(20): 0.35
MA(100): 1.37     MA(250): 8.96
MACD: MACD(12,26): -0.12     Signal(9): -0.15
Stochastic oscillator: %K(14,3): 85.44     %D(3): 70.15
RSI: RSI(14): 36.52
52-week: High: 30.03  Low: 0.28  Change(%): -98.6
Average Vol(K): 3-Month: 173965  10-Days: 80381

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
TRXC has closed below upper band by 7.7%. Bollinger Bands are 86.8% narrower than normal. The narrow width of the bands suggests low volatility as compared to TRXC's normal range. The bands have been in this narrow range for 10 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

TransEnterix, Inc. Reports Operating and Financial Results for the Fourth Quarter and Full Year 2019
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--TransEnterix, Inc. (NYSE American: TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced its operating and financial results for the fourth quarter and full-year 2019. Recent Highlights Three hospitals initiated Senhance Digital Laparoscopy Programs thus far in 2020 Announced FDA 510(k) clearance for First Machine Vision System in Robotic Surgery o

TransEnterix Receives FDA Clearance for First Machine Vision System in Robotic Surgery
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced the Company received 510(k) clearance for the Intelligent Surgical Unit (ISUTM) that enables machine vision capabilities on the SenhanceⓇ Surgical System. “We are pleased to have received this important clearance earlier than expected. Machine vision is the next

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NYSE American
Sector:  Healthcare
Industry:  Medical Instruments Supplies
Shares Out. (M) 28.90
Shares Float (M) 37.79
% Held by Insiders 8.46
% Held by Institutions 21.46
Shares Short (K) 3670
Shares Short P. Month (K) 3170

Stock Financials

EPS -8.694
Book Value (p.s.) 2.680
PEG Ratio
Profit Margin
Operating Margin -1075.38
Return on Assets (ttm) -36.5
Return on Equity (ttm) -137.6
Qtrly Rev. Growth -90.9
Gross Profit (p.s.) -0.422
Sales Per Share 0.295
EBITDA (p.s.) -2.743
Qtrly Earnings Growth
Operating Cash Flow (M) -73.48
Levered Free Cash Flow (M) -34.70

Stock Valuations

P/E -0.05
P/E Growth Ratio 0.05
P/BV 0.15
P/CF -0.16

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date 2019-12-11
Last Split Ratio 0.077
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.